Search

Your search keyword '"Teimourian S"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Teimourian S" Remove constraint Author: "Teimourian S" Search Limiters Full Text Remove constraint Search Limiters: Full Text
41 results on '"Teimourian S"'

Search Results

1. Apparent histological changes of adipocytes after treatment with CL 316,243, a ß-3-adrenergic receptor agonist

2. Synthesis and characterization of a novel chemically designed (Globo)3–DTPA–KLH antigen

3. Serum concentration of Selenium in healthy individuals living in Tehran

4. Antagonistic activities of some probiotic lactobacilli culture supernatant on Serratia marcescens swarming motility and antibiotic resistance

6. Haplotype Analysis of [Beta]-Thalassemia in Iran

9. Silica nanoparticles-induced cytotoxicity and genotoxicity in A549 cell lines.

10. High inflammatory cytokines gene expression can be detected in workers with prolonged exposure to silver and silica nanoparticles in industries.

11. Three possible diagnostic biomarkers for gastric cancer: miR-362-3p, miR-362-5p and miR-363-5p.

12. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma.

13. Study of LncRNA BANCR Expression in Tumor Tissues and Adjacent Normal Tissues in Gastric Cancer Patients.

14. An evaluation of gastric adenocarcinoma-associated CircRNAs based on microarray meta-analysis and ceRNA networks.

15. Lactobacillus spp. derived biosurfactants effect on expression of genes involved in Proteus mirabilis biofilm formation.

16. Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3 (SOCS3) Gene with Susceptibility to Crohn's Disease.

17. Update of gene expression/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy.

18. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.

19. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation.

20. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer.

21. How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.

22. Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy.

23. Slit/Robo Signaling Pathway in Cancer; a New Stand Point for Cancer Treatment.

24. Gene expression profile evaluation of integrins in 3T3-L1 cells differentiated to adipocyte, insulin resistant and hypertrophied cells.

25. Hereditary Ataxia with a Novel Mutation in the Senataxin Gene: A Case Report.

26. Characterization of two novel mutations in IL-12R signaling in MSMD patients.

27. Evaluation of the TLR negative regulatory network in CVID patients.

28. Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.

29. Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report.

30. Therapeutic applications of CRISPR/Cas9 system in gene therapy.

31. Effects of Oral Probiotic Feeding on Toll-Like Receptor Gene Expression of the Chicken's Cecal Tonsil.

32. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children.

34. CTNS molecular genetics profile in a Persian nephropathic cystinosis population.

35. An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets.

36. The role of biodegradable engineered random polycaprolactone nanofiber scaffolds seeded with nestin-positive hair follicle stem cells for tissue engineering.

37. The inhibitory effect of a Lactobacillus acidophilus derived biosurfactant on biofilm producer Serratia marcescens.

38. Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist.

39. Technology developments in biological tools for targeted genome surgery.

40. Evaluation of liver diseases in Iranian patients with primary antibody deficiencies.

41. CYBB Gene Mutation Detection in an Iranian Patient with Chronic Granulomatous Disease.

Catalog

Books, media, physical & digital resources